Admission Of New Ordinary Shares & TVR

RNS Number : 2534J

Boston International Holdings PLC

16 August 2019

 

BOSTON INTERNATIONAL HOLDINGS PLC

("BIH" or the "Company")

ADMISSION OF NEW ORDINARY SHARES

AND TOTAL VOTING RIGHTS

Further to the Company's announcement on 13 August 2019 in relation to the allotment of 6,000,000 new ordinary shares in the capital of the Company (the "New Shares"), the Company announces that the listing of the New Shares to the standard segment of the Official List of the UK Listing Authority and the admission of the New Shares to trading on the London Stock Exchange's main market for listed securities ("Admission") became effective and that dealings commenced trading at 8.00 a.m. today.

The New Shares rank pari passu in all respects with the existing ordinary shares of the Company with ISIN GB00BD70S874.

Following Admission, the Company's enlarged issued share capital will comprise 36,620,948 Ordinary Shares with one voting right per Ordinary Share.  No Ordinary Shares are held in Treasury.  The total number of voting rights in the Company is therefore 36,620,948.

This figure of 36,620,948 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

-ENDS-

BIH is a special purpose acquisition company listed on the standard segment of the official list, with shares traded on the main market of the London Stock Exchange. BIH is seeking to acquire a business operating in the foreign exchange ("FX") sector.

Enquiries:

Cairn Financial Advisers

Jo Turner/David Coffman      [phone]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

 

END

 

 

MSCEAXPSFSDNEFF